MariMed Statistics

Total Valuation

MariMed has a market cap or net worth of CAD 64.74 million. The enterprise value is 204.03 million.

Market Cap	64.74M
Enterprise Value	204.03M

Important Dates

The next estimated earnings date is Monday, March 3, 2025.

Earnings Date	Mar 3, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+6.67%
Shares Change (QoQ)	+0.29%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	342.09M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	1.40
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.09, with an EV/FCF ratio of -25.81.

EV / Earnings	-10.69
EV / Sales	0.90
EV / EBITDA	7.09
EV / EBIT	18.73
EV / FCF	-25.81

Financial Position

The company has a current ratio of 1.27, with a Debt / Equity ratio of 1.03.

Current Ratio	1.27
Quick Ratio	0.40
Debt / Equity	1.03
Debt / EBITDA	4.47
Debt / FCF	-15.29
Interest Coverage	1.15

Financial Efficiency

Return on equity (ROE) is -15.15% and return on invested capital (ROIC) is 2.79%.

Return on Equity (ROE)	-15.15%
Return on Assets (ROA)	2.35%
Return on Capital (ROIC)	2.79%
Revenue Per Employee	312,701
Profits Per Employee	-27,988
Employee Count	721
Asset Turnover	0.78
Inventory Turnover	3.05

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -64.10% in the last 52 weeks. The beta is 2.80, so MariMed's price volatility has been higher than the market average.

Beta (5Y)	2.80
52-Week Price Change	-64.10%
50-Day Moving Average	0.21
200-Day Moving Average	0.27
Relative Strength Index (RSI)	27.64
Average Volume (20 Days)	28,750

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.01

Income Statement

In the last 12 months, MariMed had revenue of CAD 213.26 million and -19.09 million in losses. Loss per share was -0.05.

Revenue	213.26M
Gross Profit	91.16M
Operating Income	10.24M
Pretax Income	-13.98M
Net Income	-19.09M
EBITDA	24.25M
EBIT	10.24M
Loss Per Share	-0.05

Full Income Statement

Balance Sheet

The company has 13.22 million in cash and 120.83 million in debt, giving a net cash position of -107.60 million.

Cash & Cash Equivalents	13.22M
Total Debt	120.83M
Net Cash	-107.60M
Net Cash Per Share	n/a
Equity (Book Value)	117.32M
Book Value Per Share	0.25
Working Capital	16.32M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 14.09 million and capital expenditures -22.00 million, giving a free cash flow of -7.90 million.

Operating Cash Flow	14.09M
Capital Expenditures	-22.00M
Free Cash Flow	-7.90M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 42.74%, with operating and profit margins of 4.80% and -8.95%.

Gross Margin	42.74%
Operating Margin	4.80%
Pretax Margin	-6.55%
Profit Margin	-8.95%
EBITDA Margin	11.37%
EBIT Margin	4.80%
FCF Margin	n/a

Dividends & Yields

MariMed does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.67%
Shareholder Yield	-6.67%
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

MariMed has an Altman Z-Score of 0.71. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.71
Piotroski F-Score	n/a